Suppr超能文献

功能完全血运重建后残余解剖学疾病负担的预后影响

Prognostic Impact of Residual Anatomic Disease Burden After Functionally Complete Revascularization.

作者信息

Lee Joo Myung, Hwang Doyeon, Choi Ki Hong, Lee Hyun-Jong, Song Young Bin, Cho Yun-Kyeong, Nam Chang-Wook, Hahn Joo-Yong, Shin Eun-Seok, Doh Joon-Hyung, Hoshino Masahiro, Hamaya Rikuta, Kanaji Yoshihisa, Murai Tadashi, Zhang Jun-Jie, Ye Fei, Li Xiaobo, Ge Zhen, Chen Shao-Liang, Kakuta Tsunekazu, Koo Bon-Kwon

机构信息

Division of Cardiology, Department of Internal Medicine, Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea (J.M.L., K.H.C., Y.B.S., J.-Y.H.).

Department of Internal Medicine and Cardiovascular Center, Seoul National University Hospital, Korea (D.H., B.-K.K.).

出版信息

Circ Cardiovasc Interv. 2020 Sep;13(9):e009232. doi: 10.1161/CIRCINTERVENTIONS.120.009232. Epub 2020 Sep 8.

Abstract

BACKGROUND

Prognostic impact of residual anatomic disease burden after functionally complete percutaneous coronary intervention (PCI), defined by post-PCI fractional flow reserve (FFR) >0.80 would be a clinically relevant question. The current study evaluated clinical outcomes at 2 years according to residual Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery (SYNTAX) score (RSS) in patients who underwent functionally complete revascularization.

METHODS

A total of 1910 patients (2095 revascularized vessels) with post-PCI FFR >0.80 were selected from the International Post-PCI FFR Registry. RSS was defined as the SYNTAX score recalculated after PCI, SYNTAX revascularization index was calculated as 100×(1-RSS/pre-PCI SYNTAX score), and post-PCI FFR was measured after completion of PCI. The primary outcome was target vessel failure (TVF; a composite of cardiac death, target vessel-related myocardial infarction, and clinically driven target vessel revascularization) at 2 years, and risk of TVF was compared according to tertile classification of RSS (0, 1-5, and >5) and post-PCI FFR (≥0.94, 0.87-0.93, and ≤0.86).

RESULTS

After PCI, SYNTAX score was changed from 10.0 (Q1-Q3, 7.0-16.0) to 0.0 (Q1-Q3, 0.0-5.0) and FFR changed from 0.70±0.12 to 0.90±0.05. TVF at 2 years occurred in 4.9%, and patients with TVF showed higher pre-PCI SYNTAX score and lower post-PCI FFR than those without. However, there were no significant differences in SYNTAX revascularization index and RSS. The risk of TVF was not different according to tertile of RSS (log-rank =0.851). Conversely, risk of TVF was different according to tertile of post-PCI FFR (log-rank =0.009). Multivariable model showed the risk of TVF was significantly associated with post-PCI FFR (hazard ratio, 1.091 [95% CI, 1.032-1.153]; =0.002) but not with RSS (hazard ratio, 0.969 [95% CI, 0.898-1.045]; =0.417).

CONCLUSIONS

Among patients who underwent functionally complete revascularization, residual anatomic disease burden assessed by RSS was not related with occurrence of TVF at 2 years. These results support the importance of functionally complete revascularization rather than angiographic complete revascularization. Registration: URL: https://www.clinicaltrials.gov. Unique identifier: NCT04012281.

摘要

背景

在经皮冠状动脉介入治疗(PCI)功能上完全实现血运重建后,由PCI术后血流储备分数(FFR)>0.80所定义的残余解剖学疾病负担的预后影响是一个具有临床相关性的问题。本研究根据残余的经皮冠状动脉介入治疗与心脏手术协同作用(SYNTAX)评分(RSS),评估了功能上完全实现血运重建的患者2年时的临床结局。

方法

从国际PCI术后FFR注册研究中选取了1910例PCI术后FFR>0.80的患者(2095条血运重建血管)。RSS定义为PCI后重新计算的SYNTAX评分,SYNTAX血运重建指数计算为100×(1 - RSS/PCI术前SYNTAX评分),PCI完成后测量PCI术后FFR。主要结局是2年时的靶血管失败(TVF;包括心源性死亡、靶血管相关心肌梗死和临床驱动的靶血管血运重建的复合终点),并根据RSS(0、1 - 5和>5)和PCI术后FFR(≥0.94、0.87 - 0.93和≤0.86)的三分位数分类比较TVF风险。

结果

PCI术后,SYNTAX评分从10.0(四分位数间距,7.0 - 16.0)变为0.0(四分位数间距,0.0 - 5.0),FFR从0.70±0.12变为0.90±0.05。2年时TVF发生率为4.9%,发生TVF的患者PCI术前SYNTAX评分更高,PCI术后FFR更低。然而,SYNTAX血运重建指数和RSS无显著差异。根据RSS三分位数,TVF风险无差异(对数秩检验=0.851)。相反,根据PCI术后FFR三分位数,TVF风险有差异(对数秩检验=0.009)。多变量模型显示,TVF风险与PCI术后FFR显著相关(风险比,1.091[95%可信区间,1.032 - 1.153];P=0.002),但与RSS无关(风险比,0.969[95%可信区间,0.898 - 1.045];P=0.417)。

结论

在功能上完全实现血运重建的患者中,通过RSS评估的残余解剖学疾病负担与2年时TVF的发生无关。这些结果支持了功能上完全实现血运重建而非血管造影完全实现血运重建的重要性。注册:网址:https://www.clinicaltrials.gov。唯一标识符:NCT04012281。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验